BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33242451)

  • 21. Prevalence of Epstein–Barr Virus Genotypes in Pakistani Lymphoma Patients.
    Salahuddin S; Khan J; Azhar J; B. Whitehurst C; Qadri I; Shackelford J; Pagano JS; Muhammad D; Richards KL
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3153-3159. PubMed ID: 30486603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes.
    Midgley RS; Bell AI; McGeoch DJ; Rickinson AB
    J Virol; 2003 Nov; 77(21):11517-30. PubMed ID: 14557637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.
    Palser AL; Grayson NE; White RE; Corton C; Correia S; Ba Abdullah MM; Watson SJ; Cotten M; Arrand JR; Murray PG; Allday MJ; Rickinson AB; Young LS; Farrell PJ; Kellam P
    J Virol; 2015 May; 89(10):5222-37. PubMed ID: 25787276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
    Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type.
    Suzuki R; Yamaguchi M; Izutsu K; Yamamoto G; Takada K; Harabuchi Y; Isobe Y; Gomyo H; Koike T; Okamoto M; Hyo R; Suzumiya J; Nakamura S; Kawa K; Oshimi K;
    Blood; 2011 Dec; 118(23):6018-22. PubMed ID: 21984805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of Epstein–Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Patients with Ductal Breast Carcinoma.
    Sharifpour C; Makvandi M; Samarbafzadeh A; Talaei-Zadeh A; Ranjbari N; Nisi N; Azaran A; Jalilian S; Varnaseri M; Pirmoradi R; Ahmadi Angali K
    Asian Pac J Cancer Prev; 2019 Mar; 20(3):687-692. PubMed ID: 30909665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cell adhesion molecules and chemokine receptors: angioinvasiveness in nasal NK/T-cell lymphoma.
    Liu A; Nakatsuka S; Yang WI; Kojya S; Aozasa K
    Oncol Rep; 2005 Apr; 13(4):613-20. PubMed ID: 15756432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase.
    Wang L; Wang H; Wang JH; Xia ZJ; Lu Y; Huang HQ; Jiang WQ; Zhang YJ
    Oncotarget; 2015 Oct; 6(30):30317-26. PubMed ID: 26210287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genotypic analysis and latent membrane protein 1 expression of Epstein-Barr virus in extranodal NK/T-cell lymphoma from Northern Chinese patients.
    Wang H; Li H; Xing X; Zhao C; Luo B
    Arch Virol; 2015 Aug; 160(8):2071-4. PubMed ID: 26008210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epstein-Barr virus nuclear antigen (EBNA)-1 carboxy-terminal and EBNA-4 sequence polymorphisms in nasal natural killer/T-cell lymphoma in the United States.
    Gaal K; Weiss LM; Chen WG; Chen YY; Arber DA
    Lab Invest; 2002 Jul; 82(7):957-62. PubMed ID: 12118098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
    Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
    Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasopharyngeal extranodal NK/T-cell lymphoma, nasal type: retrospective study of 18 consecutive cases in Guangzhou, China.
    Huang YH; Wu QL; Zong YS; Feng YF; Hou JH
    Int J Surg Pathol; 2011 Feb; 19(1):51-61. PubMed ID: 21134987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus molecular epidemiology and variants identification in head and neck squamous cell carcinoma.
    Karbalaie Niya MH; Safarnezhad Tameshkel F; Keyvani H; Esghaei M; Panahi M; Zamani F; Tabibzadeh A
    Eur J Cancer Prev; 2020 Nov; 29(6):523-530. PubMed ID: 31738221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Cancer Sci; 2008 Aug; 99(8):1633-42. PubMed ID: 18754877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan.
    Higa M; Kinjo T; Kamiyama K; Iwamasa T; Hamada T; Iyama K
    J Clin Pathol; 2002 Jun; 55(6):414-23. PubMed ID: 12037022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Chiang AK; Tao Q; Srivastava G; Ho FC
    Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of the 30 base pair deletion of Epstein-Barr virus latent membrane protein 1 in extranodal nasal type NK/T-cell lymphoma and its prognostic significance].
    Zhao S; Liu WP; Wang XL; Zhang WY; Jiang W; Tang Y; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2005 Nov; 34(11):720-3. PubMed ID: 16536316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.